Publications of Institute of Radiopharmaceutical Cancer Research - Year 2022
12 Publications2022
Synthesis and preclinical evaluation of rhenium and technetium-99m “4 + 1” mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents
Kiritsis, C.; Shegani, A.; Makrypidi, K.; Roupa, I.; Lazopoulos, A.; et al. (12 authors)
-
Bioorganic & Medicinal Chemistry 73(2022), 117012
DOI: 10.1016/j.bmc.2022.117012
Towards personalized medicine: one chelator for imaging and therapy with lutetium-177 and actinium-225
Cieslik, P.; Kubeil, M.; Zarschler, K.; Ullrich, M.; Brandt, F.; et al. (12 authors)
-
Journal of the American Chemical Society 144(2022)47, 21555-21567
DOI: 10.1021/jacs.2c08438
Efficient Production of the PET radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy using the 134Ba(p,2n)133La Reaction
Brühlmann, S. A.; Kreller, M.; Pietzsch, H.-J.; Kopka, K.; Mamat, C.; et al. (7 authors)
-
Pharmaceuticals 15(2022), 1167
DOI: 10.3390/ph15101167
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
Krutzek, F.; Kopka, K.; Stadlbauer, S.
-
Pharmaceuticals 15(2022), 747
DOI: 10.3390/ph15060747
Cyclam with a phosphinate-bis(phosphonate) pendant arm is a bone-targeting carrier of copper radionuclides
Pazderová, L.; Benešová, M.; Havlíčková, J.; Vojtíčková, M.; Kotek, J.; et al. (15 authors)
-
Dalton Transactions 51(2022), 9541-9555
DOI: 10.1039/d2dt01172g
Calix[4]crowns with perfluoroalkylsulfonylcarboxamide functions: a complexation approach for heavy group 2 metal ions
Reissig, F.; Bauer, D.; Al-Ameed, K.; Luber, S.; Köckerling, M.; et al. (8 authors)
-
Inorganic Chemistry Frontiers 10(2023), 370-382
Online First (2022) DOI: 10.1039/d2qi01637k
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin
Reissig, F.; Zarschler, K.; Novy, Z.; Petrik, M.; Bendova, K.; et al. (14 authors)
-
Theranostics 12(2022), 7203-7215
DOI: 10.7150/thno.78043
Introducing micro physiological systems to evaluate new radiopharmaceuticals: First attempts with radiolabeled cetuximab
Sihver, W.; Nitt-Weber, A.-K.; Behrens, S.; Ullrich, M.; Pietzsch, H.-J.; et al. (8 authors)
-
Current Directions in Biomedical Engineering 8(2022)2, 532-535
DOI: 10.1515/cdbme-2022-1136
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives
Kubeil, M.; Santana Martinez, I. I.; Bachmann, M.; Kopka, K.; Tuck L., K.; et al. (6 authors)
-
Pharmaceuticals 15(2022), 432
DOI: 10.3390/ph15040432
Strained Ammonium Precursors for Radiofluorinations
-
ChemistryOpen 11(2022), e202200039
DOI: 10.1002/open.202200039
Bis(amido)bis(oxinate)diamine ligands for theranostic radiometals
Southcott, L.; Whetter, J. N.; Wharton, L.; Patrick, B. O.; Zarschler, K.; et al. (9 authors)
-
Journal of Inorganic Biochemistry 231(2022), 111789
DOI: 10.1016/j.jinorgbio.2022.111789
Preparation of calix[4]arenes for chelation of selected divalent cations
Blumberg, M.; Al-Ameed, K.; Eiselt, E.; Luber, S.; Mamat, C.
-
Molecules 27(2022)5, 1478
DOI: 10.3390/molecules27051478
